Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hema Diagnostic Systems
Miramar, Florida, United States
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Hema Diagnostic Systems develops, manufactures, and commercializes rapid point-of-care in‑vitro diagnostic assays for major infectious diseases worldwide, using proprietary delivery formats; products appear to be commercially deployed rather than in formal therapeutic clinical phases.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceDiagnostic test
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Generex Biotechnology (controlling/major equity interest and integration into its diagnostics portfolio)
Beyond the preview
Go deeper on Hema Diagnostic Systems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hema Diagnostic Systems.